High-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN-HFS) is the
preferred surgical treatment for advanced Parkinson's disease. In the 15 years since its …

Parkinson's disease is the most common serious movement disorder in the world, affecting
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …

Object Deep brain stimulation (DBS) surgery is increasingly prominent in the treatment of
various disorders refractory to medication. Despite the procedure's efficacy, the community …

Short-term symptomatic treatment and dose-dependent side effects of pharmacological
treatment for neurodegenerative diseases have forced the medical community to seek an …

Deep brain stimulation (DBS) is associated with significant improvement of motor
complications in patients with severe Parkinson's disease after some 6–12 months of …

Psychiatric neurosurgery teams in the United States and Europe have studied deep brain
stimulation (DBS) of the ventral anterior limb of the internal capsule and adjacent ventral …

Object Hemorrhagic complications carry by far the highest risk of devastating neurological
outcome in functional neurosurgery. Literature published over the past 10 years suggests …

Objective: To make evidence-based treatment recommendations for the medical and
surgical treatment of patients with Parkinson disease (PD) with levodopa-induced motor …

Parkinson's disease (PD) affects one in every 100 persons above the age of 65 years,
making it the second most common neurodegenerative disease after Alzheimer's disease …

Objective: To define key issues in the diagnosis of Parkinson disease (PD), to define
features influencing progression, and to make evidence-based recommendations. Two …